S3252 Ghosts of Nephrectomies Past: Renal Cell Carcinoma's Pancreatic Plot Twist

Introduction: Renal cell carcinoma (RCC) is notorious for its potential to metastasize, particularly to the lungs, bones, and liver although pancreatic involvement is relatively rare, RCC remains a common cause of pancreatic metastasis. Imaging characteristics of RCC metastasis to the pancreas include hypervascular metastatic foci that are well defined with discrete margins. We present a case of a patient with a history of RCC who was found to have pancreatic metastasis with diffuse involvement of the pancreas. Case Description/Methods: A 69-year-old woman with a history of RCC status post left nephrectomy in 2007 presented to clinic with a 1-week history of a “pulsatile abdomen”. Computed tomography imaging revealed a diffusely infiltrative hyperenhancing pancreatic mass suspicious for a neuroendocrine tumor (NET). She subsequently underwent endoscopic ultrasound with biopsy, and pathology confirmed metastatic RCC to the pancreas. Positron emission tomography scan showed a large infiltrative mass involving the pancreatic head, body, and most of the tail, with likely invasion of the portal vein and superior mesenteric vein. A left upper lobe lung nodule was also noted, concerning for metastasis. The patient was started on palliative treatment with pembrolizumab and axitinib. Discussion: RCC is one of the most common primary tumors to metastasize to the pancreas even decades after nephrectomy. Pancreatic metastases from RCC typically present as hypervascular lesions with discrete borders on imaging. However, differentiating RCC metastases from neuroendocrine tumors (NETs) from imaging alone remains challenging, as both exhibit similar vascular patterns. RCC has distinguishing features, such as pancreatic and biliary ductal invasion causing jaundice – less common in NETs – and absence of hormone-related symptoms seen in functional NETs. Ultimately, histologic confirmation via endoscopic ultrasound-guided biopsy is essential for definitive diagnosis. Awareness of a prior RCC diagnosis is critical and any hypervascular pancreatic lesion in such patients should prompt strong suspicion for metastatic disease. Notably, when confined to the pancreas, RCC metastases carry a more favorable prognosis.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001140468.81598.d9
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3252 Ghosts of Nephrectomies Past: Renal Cell Carcinoma's Pancreatic Plot Twist

Victoria A. Margolis, Janki Patel, Jason Conway
The American Journal of Gastroenterology
Renal cell carcinoma treatment
article

S3252 Ghosts of Nephrectomies Past: Renal Cell Carcinoma's Pancreatic Plot Twist

Victoria A. Margolis, Janki Patel, Jason Conway
article en

Abstract

Introduction: Renal cell carcinoma (RCC) is notorious for its potential to metastasize, particularly to the lungs, bones, and liver although pancreatic involvement is relatively rare, RCC remains a common cause of pancreatic metastasis. Imaging characteristics of RCC metastasis to the pancreas include hypervascular metastatic foci that are well defined with discrete margins. We present a case of a patient with a history of RCC who was found to have pancreatic metastasis with diffuse involvement of the pancreas. Case Description/Methods: A 69-year-old woman with a history of RCC status post left nephrectomy in 2007 presented to clinic with a 1-week history of a “pulsatile abdomen”. Computed tomography imaging revealed a diffusely infiltrative hyperenhancing pancreatic mass suspicious for a neuroendocrine tumor (NET). She subsequently underwent endoscopic ultrasound with biopsy, and pathology confirmed metastatic RCC to the pancreas. Positron emission tomography scan showed a large infiltrative mass involving the pancreatic head, body, and most of the tail, with likely invasion of the portal vein and superior mesenteric vein. A left upper lobe lung nodule was also noted, concerning for metastasis. The patient was started on palliative treatment with pembrolizumab and axitinib. Discussion: RCC is one of the most common primary tumors to metastasize to the pancreas even decades after nephrectomy. Pancreatic metastases from RCC typically present as hypervascular lesions with discrete borders on imaging. However, differentiating RCC metastases from neuroendocrine tumors (NETs) from imaging alone remains challenging, as both exhibit similar vascular patterns. RCC has distinguishing features, such as pancreatic and biliary ductal invasion causing jaundice – less common in NETs – and absence of hormone-related symptoms seen in functional NETs. Ultimately, histologic confirmation via endoscopic ultrasound-guided biopsy is essential for definitive diagnosis. Awareness of a prior RCC diagnosis is critical and any hypervascular pancreatic lesion in such patients should prompt strong suspicion for metastatic disease. Notably, when confined to the pancreas, RCC metastases carry a more favorable prognosis.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 56%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

S3252 Ghosts of Nephrectomies Past: Renal Cell Carcinoma's Pancreatic Plot Twist — Victoria A. Margolis, Janki Patel, et al. · The American Journal of Gastroenterology (2025) | TGRS Research Map | TGRS